Michel Legros
About
In The Last Decade
Michel Legros
50 papers receiving 785 citations
Peers
Comparison fields: 5 of 87
- Oncology 397
- Hematology 237
- Pathology and Forensic Medicine 162
- Pulmonary and Respiratory Medicine 147
- Reproductive Medicine 143
Countries citing papers authored by Michel Legros
This map shows the geographic impact of Michel Legros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Legros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Legros more than expected).
Fields of papers citing papers by Michel Legros
This network shows the impact of papers produced by Michel Legros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Legros. The network helps show where Michel Legros may publish in the future.
Co-authorship network of co-authors of Michel Legros
This figure shows the co-authorship network connecting the top 25 collaborators of Michel Legros. A scholar is included among the top collaborators of Michel Legros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Legros. Michel Legros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 24 | |
| 3 | 22 | |
| 4 | 72 | |
| 5 | 19 | |
| 6 | [Role of super selective arteriography with embolization in the treatment of severe epistaxis: our experience apropos of 16 cases]. | 1 |
| 7 | 3 | |
| 8 | 135 | |
| 9 | A PHASE-III RANDOMIZED PLACEBO-CONTROLED STUDY IN 315 PEDIATRIC AND ADULT AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH LENOGRASTIM-5 UG/KG/DAY (GLYCOSYLATED RHU-G-CSF) | 4 |
| 10 | 16 | |
| 11 | 8 | |
| 12 | 79 | |
| 13 | Hautes doses d'alkylants et autogreffe de moelle dans les cancers de l'ovaire à mauvais pronostic : une analyse rétrospective de 40 patientes traitées en France | 0 |
| 14 | 24 | |
| 15 | [Epithelial cancer of the ovary. Contribution of the experiences of a treatment facility to the current data of prognosis and treatment]. | 2 |
| 16 | 7 | |
| 17 | 31 | |
| 18 | 7 | |
| 19 | 68 | |
| 20 | [Sequential trials in initial chemotherapy of advanced tumors of the upper aero-digestive system. Cis-diamminedichloroplatinum (DDP) versus DDP-etoposide (VP16)]. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.